Synaptogenesis and myopathy under acetylcholinesterase overexpression (original) (raw)

• Andres C., Beeri R., Friedman A., Lev-Lehman E., Henis S., Timberg R., et al. (1997). Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. USA 94, 8173–8178.
  Article PubMed CAS Google Scholar
• Andres C., Seidman S., Beeri R., Timberg R., and Soreq H. (1998) Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact. Neurochem Int. 32, 449–456.
  Article PubMed CAS Google Scholar
• Ben Aziz Aloya R., Seidman S., Timberg R., Sternfeld M., Zakut H., and Soreq H. (1993). Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. Proc. Natl. Acad. Sci. USA 90, 2471–2475.
  Article PubMed CAS Google Scholar
• Chollat Namy A., Delamanche I. S., and Bouchaud C. (1993) Variation in the expression of c-fos after intoxication by soman. Comparative study using in situ hybridization and immunohistochemistry. Brain Res. 603, 32–37.
  Article PubMed CAS Google Scholar
• Darboux I., Barthalay Y., Piovant M., and Hipeau Jacquotte R. (1996) The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15, 4835–4843.
  Google Scholar
• de la Escalera S., Bockamp E. O., Moya F., Piovant M., and Jimenez F. (1990) Characterization and gene cloning of neurotactin, a Drosophila transmembrane protein related to cholinesterases. EMBO J. 9, 3593–3601.
  PubMed Google Scholar
• Donger C., Krejci E., Serradell A. P., Eymard B., Bon S., Nicole S., et al. (1998). Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). Am. J. Hum. Genet. 63, 967–975.
  Article PubMed CAS Google Scholar
• Engel A. G., Lambert E. H., and Santa T. (1973) Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor endplate fine structure. Neurology 23, 1273–1281.
  PubMed CAS Google Scholar
• Engelhardt J. I., Siklos L., and Appel S. H. (1997) Immunization of guinea pigs with human choline acetyltransferase induces selective lower motoneuron destruction. J. Neuroimmunol. 78, 57–68.
  Article PubMed CAS Google Scholar
• Evoli A., Batocchi A. P., and Tonali P. (1996) A practical guide to the recognition and management of myasthenia gravis. Drugs 52, 662–670.
  Article Google Scholar
• Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., and Tur Kaspa I. (1996). Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2, 1382–1385.
  Article Google Scholar
• Gibbs R. B. and Martynowski C. (1997). Nerve growth factor induces Fos-like immunoreactivity within identified cholinergic neurons in the adult rat basal forebrain. Brain Res. 753, 141–151.
  Article PubMed CAS Google Scholar
• Grifman M., Galyam N., Seidman S., and Soreq H. (1998) Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc. Natl. Acad. Sci. USA 95, 13,935–13,940.
  Article CAS Google Scholar
• Grisaru D., Lev-Lehman E., Shapira M., Chaikin E., Lessing J. B., Eldor A., et al. (1999) Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3′ alternative splicing variant of acetylcholinesterase. Mol. Cell Biol. 19, 788–795.
  PubMed CAS Google Scholar
• Haley R. W., Kurt T. L., and Hom J. (1997) Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 277, 215–222.
  Article PubMed CAS Google Scholar
• Hudson C. S., Rash J. E., Tiedt T. N., and Albuquerque E. X. (1978) Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure. J. Pharmacol. Exp. Ther. 205, 340–356.
  PubMed CAS Google Scholar
• Ichtchenko K., Hata Y., Nguyen T., Ullrich B., Missler M., Moomaw C., and Sudhof T. C. (1995). Neuroligin 1: a splice site-specific ligand for betaneurexins. Cell 81, 435–443.
  Article PubMed CAS Google Scholar
• Jasmin B. J., Lee R. K., and Rotundo R. L. (1993) Compartmentalization of acetylcholinesterase mRNA and enzyme at the vertebrate neuromuscular junction. Neuron 11, 467–477.
  Article PubMed CAS Google Scholar
• Kaufer D., Friedman A., and Soreq H. (1999) The vicious circle of stress and anticholinesterase responses. Neuroscientist 5, 173–183.
  Article CAS Google Scholar
• Kaufer D., Friedman A., Seidman S., and Soreq H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373–377.
  Article PubMed CAS Google Scholar
• Kawabuchi M., Osame M., Watanabe S., Igata A., and Kanaseki T. (1976) Myopathic changes at the end-plate region induced by neostigmine methylsulfate. Experientia 32, 632–635.
  Article PubMed CAS Google Scholar
• Koenigsberger C., Chiappa S., and Brimijoin S. (1997) Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression. J. Neurochem. 69, 1389–1397.
  Article PubMed CAS Google Scholar
• Laskowski M. B., Olson W. H., and Dettbarn W. D. (1975) Ultrastructural changes at the motor end-plant produced by an irreversible cholinesterase inhibitor. Exp. Neurol. 47, 290–306.
  Article PubMed CAS Google Scholar
• Layer P. G. and Willbold E. (1995) Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29, 1–99.
  PubMed CAS Google Scholar
• Lindstrom J. (1998) Mutations causing muscle weakness. Proc. Natl. Acad. Sci. USA 95, 9070,9071.
  Article PubMed CAS Google Scholar
• Livneh A., Sarova I., Michaeli D., Pras M., Wagner K., Zakut H., and Soreq H. (1988). Antibodies against acetylcholinesterase and low levels of cholinesterases in a patient with an atypical neuromuscular disorder. Clin. Immunol. Immunopathol. 48, 119–131.
  Article PubMed CAS Google Scholar
• Massoulie J., Pezzementi L., Bon S., Krejci E., and Vallette F. M. (1993) Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31–91.
  Article PubMed CAS Google Scholar
• Sanes J. R. and Lichtman J. W. (1999) Development of the vertebrate neuromuscular junction. Ann. Rev. Neurosci. 22, 389–442.
  Article PubMed CAS Google Scholar
• Schonbeck S., Chrestel S., and Hohlfeld R. (1990) Myasthenia gravis: prototype of the antireceptor autoimmune diseases. Int. Rev. Neurobiol. 32, 175–200.
  PubMed CAS Google Scholar
• Seidman S., Sternfeld M., Ben Aziz Aloya R., Timberg R., Kaufer Nachum D., and Soreq H. (1995). Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3′-terminal exons. Mol. Cell Biol. 15, 2993–3002.
  PubMed CAS Google Scholar
• Seidman S., Eckstein F., Grifman M., and Soreq H. Antisense technologies have a future combating neurodegenerative disease. Antisense Res. Drug Dev. 9, 333–340.
• Shapira M., Seidman S., Sternfeld M., Timberg R., Kaufer D., Patrick J., and Soreq H. (1994). Transgenic engineering of neuromuscular junctions in Xenopus laevis embryos transiently overexpressing key cholinergic proteins. Proc. Natl. Acad. Sci. USA 91, 9072–9076.
  Article PubMed CAS Google Scholar
• Sharma K. V. and Bigbee J. W. (1998) Acetylcholinesterase antibody treatment results in neurite detachment and reduced outgrowth from cultured neurons: further evidence for a cell adhesive role for neuronal acetylcholinesterase. J. Neurosci. Res. 53, 454–464.
  Article PubMed CAS Google Scholar
• Slotkin T. A., McCook E. C., and Seidler F. J. (1997) Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res. 750, 180–188.
  Article PubMed CAS Google Scholar
• Sternfeld M., Ming G., Song H., Sela K., Timberg R., Poo M., and Soreq H. (1998). Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18, 1240–1249.
  PubMed CAS Google Scholar
• Sternfeld M., Patrick J. D., and Soreq H. (1998) Position effect variegations and brain-specific silencing in transgenic mice overexpressing human acetylcholinesterase variants. J. Physiol. (Paris) 92, 249–255.
  Article CAS Google Scholar
• Swash M. (1975) Motor innervation of myasthenic muscles (Letter). Lancet 2, 663.
  Article PubMed CAS Google Scholar
• Taylor P. (1996) Agents acting at the neuromuscular junction and autonomic ganglia, in Goodman and Gilman’s The Pharmacological Basis of Therapeutics (Hardman J. G., Limbird L. E., Molinoff P. B., and Ruddon R. W., eds.), McGraw-Hill, New York, pp. 177–197.
  Google Scholar
• Taylor P., Radic Z., Hosea N. A., Camp S., Marchot P., and Berman H. A. (1995). Structural bases for the specificity of cholinesterase catalysis and inhibition. Toxicol. Lett. 82–83, 453–458.
  Article PubMed Google Scholar